Crux Biomedical is a biotech company focused on developing solutions for the clinical limitations of current vena cava filters.
Business Model:
Revenue: $10M
Employees: 2-10
Crux Biomedical was acquired by
Volcano Corporation.
The acquisition happend on 2012-12-03.
Details of the transaction were not public
Address:
City: Menlo Park
State: California
Zip:
Country: United States
Crux Biomedical, Inc., was formed in August 2004 by physicians Tom Fogarty and Frank Arko based upon their observations of the clinical limitations of current vena cava filters.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2009 | Series B | 2 | $8M |
Alloy Ventures Thomas Fogarty Alloy Ventures Thomas Fogarty |
6/2011 | Series C | 3 | $12M |
Alloy Ventures Emergent Medical Partners Three Arch Partners Alloy Ventures Emergent Medical Partners Three Arch Partners |
9/2007 | Venture Round | 1 | $250k |
Hercules Capital Hercules Capital |
7/2005 | Series A | $3.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|